Overall Technical outlook

Price Summary

Piramal Pharma Limited's stock opened at 200.39 on 2025-09-05, surged to a high of 202.49, hit a low of 199.76, and closed up 0.13% at 200.65, with 2738830 shares traded.
During the 52-week span, the stock hit a high of 293.55 and a low of 183.44.
The projected price range for Piramal Pharma Limited is between 230.0 and 305.0, with an expected mean price of 256.66666, according to 9 analysts.

Technicals

Support and Resistance: The price sits at 200.65, supported by 192.03 and resisted by 201.82. This indicates a trading range where 192.03 provides a floor, preventing declines, and 201.82 acts as a ceiling, limiting further price increases for PPLPHARMA.
PPLPHARMA supportResistance e6dcc6
Support/Resistance for PPLPHARMA


Aroon: The AROON is in a neutral stance for PPLPHARMA, not indicating a clear upward or downward trend. This suggests a period of market indecision, where neither bulls nor bears have the upper hand.
PPLPHARMA aroon e6dcc6
Aroon chart for Piramal Pharma Limited


Bol. Bands: The current price has broken above the upper Bollinger Band, signaling a bullish move for PPLPHARMA in its latest action. This breakout suggests that buying momentum is building, driving the price higher than usual. Traders may view this as a positive sign, indicating the possibility of continued price increases.
PPLPHARMA bbands e6dcc6
Bolinger Bands chart for Piramal Pharma Limited


Parabolic SAR: The PSAR for PPLPHARMA maintains a bullish outlook, establishing a crucial support level that may help maintain the current upward momentum. This strong support suggests that the market is poised to continue its upward trend, providing confidence in the ongoing bullish sentiment.
PPLPHARMA psar e6dcc6
Parabolic Stop and Reverse chart for Piramal Pharma Limited


Stochastic: The stochastic indicator shows a bullish trend for PPLPHARMA, with the K-line positioned above the D-line and surpassing the 80 level. This setup indicates strong upward momentum, suggesting that the market may continue its positive trajectory. Traders might view this as a sign of ongoing strength in the market.
PPLPHARMA stoch e6dcc6
Stochastic chart for Piramal Pharma Limited


Tripple Moving Agerage: The Tripple MOVING AVG is showing a neutral stance, with no definitive indication of an upward or downward trend for PPLPHARMA. This neutral position suggests a period of indecision in the market, making it difficult to predict the next move.
PPLPHARMA trippleSMA e6dcc6
Tripple SMA chart for Piramal Pharma Limited


The technical analysis of a company's stock performance is valuable, but only when considered in conjunction with the company's fundamentals. These fundamentals, including financial strength, earnings growth, and leadership, provide a foundation for understanding market movements. Additionally, industry trends and competitive pressures play an important role. By integrating both fundamental and technical analysis, one can better evaluate the company's true potential and make more informed investment decisions.